Differin®

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA, Sun Pharmaceutical Industries, Inc.

Conditions

Acne Vulgaris

Phase 1

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

CompletedNCT01182636

Teva Pharmaceuticals USAAcne Vulgaris

Start: 2007-07-31End: 2008-04-30Updated: 2010-11-24

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

CompletedNCT02411942

Sun Pharmaceutical Industries, Inc.Acne Vulgaris

Start: 2014-08-31End: 2015-02-28Updated: 2017-05-04